NCT07206589View on ClinicalTrials.gov

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

1,010

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
Barrett EsophagusEsophageal Adenocarcinoma
Interventions
OTHER

Cancer Screening

Undergo BE-SOS test

OTHER

Computer-Assisted Intervention

Undergo BE risk assessment using AI powered BE Risk Tool

PROCEDURE

Endoscopic Procedure

Undergo endoscopy

BEHAVIORAL

Health Risk Assessment

Undergo manual BE risk assessment

OTHER

Navigation

Receive RN navigation

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (3)

54701

Mayo Clinic Health System-Eau Claire Clinic, Eau Claire

55905

Mayo Clinic in Rochester, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT07206589 - Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial | Biotech Hunter | Biotech Hunter